Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Renalvip is a natural herbal supplement developed by Royal Medicalink Pharma for kidney and urinary tract support, particularly in patients with chronic kidney disease (CKD) and urolithiasis (urinary tract stones). It is formulated as a combination of traditional Indonesian medicinal plant extracts, including *Sonchus arvensis* folium (tempuyung), *Orthosiphon aristatus* folium (kumis kucing), *Nigella sativa* semen (black seed), and *Phaleria macrocarpa* fructus (mahkota dewa). Renalvip is designed to support healthy kidney function, facilitate urination (diuresis), and assist in the management of urinary tract stones and fluid balance without placing undue stress on the glomerular filtration rate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Renalvip.